accountrobust and many patent expirations are coming up," Mr. Shearer said. "We also have a more aggressive Food and Drug Administration." Write to Karen Talley at karen.talley@dowjones.com...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Dividend Play Needs Diversity
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account